DE69104067D1 - Pyrimido-benzothiazine mit Lipoxygenase-hemmung. - Google Patents

Pyrimido-benzothiazine mit Lipoxygenase-hemmung.

Info

Publication number
DE69104067D1
DE69104067D1 DE69104067T DE69104067T DE69104067D1 DE 69104067 D1 DE69104067 D1 DE 69104067D1 DE 69104067 T DE69104067 T DE 69104067T DE 69104067 T DE69104067 T DE 69104067T DE 69104067 D1 DE69104067 D1 DE 69104067D1
Authority
DE
Germany
Prior art keywords
pyrimido
benzothiazine
compounds
lipoxygenase inhibition
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69104067T
Other languages
English (en)
Other versions
DE69104067T2 (de
Inventor
Kaoru Shimada
Yuji Shishido
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE69104067D1 publication Critical patent/DE69104067D1/de
Application granted granted Critical
Publication of DE69104067T2 publication Critical patent/DE69104067T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69104067T 1991-01-07 1991-12-16 Pyrimido-benzothiazine mit Lipoxygenase-hemmung. Expired - Fee Related DE69104067T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3000159A JPH0739422B2 (ja) 1991-01-07 1991-01-07 新規ピリミド−ベンゾチアジン類および組成物
PCT/US1991/009161 WO1992012161A1 (en) 1991-01-07 1991-12-16 Novel pyrimido-benzothiazines

Publications (2)

Publication Number Publication Date
DE69104067D1 true DE69104067D1 (de) 1994-10-20
DE69104067T2 DE69104067T2 (de) 1995-02-02

Family

ID=11466261

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69104067T Expired - Fee Related DE69104067T2 (de) 1991-01-07 1991-12-16 Pyrimido-benzothiazine mit Lipoxygenase-hemmung.

Country Status (11)

Country Link
EP (1) EP0566592B1 (de)
JP (1) JPH0739422B2 (de)
AT (1) ATE111469T1 (de)
CA (1) CA2099558A1 (de)
DE (1) DE69104067T2 (de)
DK (1) DK0566592T3 (de)
ES (1) ES2059209T3 (de)
FI (1) FI933102A (de)
IE (1) IE64069B1 (de)
PT (1) PT99979A (de)
WO (1) WO1992012161A1 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1175581A (en) * 1966-11-08 1969-12-23 Pfizer & Co C Pyrimidobenzothiazines and related Compounds
US4845083A (en) * 1983-10-05 1989-07-04 Merck Frosst Canada, Inc. Method of inhibiting mammalian leukotriene biosynthesis

Also Published As

Publication number Publication date
JPH0739422B2 (ja) 1995-05-01
WO1992012161A1 (en) 1992-07-23
IE920028A1 (en) 1992-07-15
DK0566592T3 (da) 1994-10-17
ATE111469T1 (de) 1994-09-15
EP0566592A1 (de) 1993-10-27
CA2099558A1 (en) 1992-07-08
JPH04230690A (ja) 1992-08-19
PT99979A (pt) 1993-01-29
EP0566592B1 (de) 1994-09-14
IE64069B1 (en) 1995-07-12
FI933102A0 (fi) 1993-07-06
FI933102A (fi) 1993-07-06
ES2059209T3 (es) 1994-11-01
DE69104067T2 (de) 1995-02-02

Similar Documents

Publication Publication Date Title
NO995544D0 (no) Forbindelser og metoder for inhibering av ekspresjonen av VCAM-1
DE122006000010I1 (de) Benzocyclobutyl- oder Indanyl-Alkyl-Amino-Alkyl substituierte 3- Benzazepin-2-ones, verwendbar in der Behandlung von kardiovaskularen Krankheiten
DK0805796T3 (da) Celleadhæsionsinhiberende forbindelser
EA200200262A1 (ru) Пиперазиновые производные и их применение в качестве противовоспалительных агентов
YU186291A (sh) Novi derivati hidroksamske kiseline i n-hidroksikarbamida
PT705100E (pt) Guanidinas substituidas terapeuticas
TR200102072T2 (tr) İltihap karşıtı maddeler olarak aromatik çok döngülü bileşimler
FI964681A0 (fi) Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
ES2192839T3 (es) Timosina beta 4 oxidada.
EA200000911A1 (ru) Новые кристаллические формы антивирусного соединения бензимидазола
EA200100732A1 (ru) Противовоспалительные и иммуносупрессорные соединения, ингибирующие клеточную адгезию
FI931204A (fi) Nya, saosom lipooxigenasinhibitorer verkande aminobensosultamderivat
DE69104067T2 (de) Pyrimido-benzothiazine mit Lipoxygenase-hemmung.
ATE110714T1 (de) Derivate von hydroxaminsäure die lipoxygenase hemmen.
NO962221L (no) Anvendelse av dimeticon for behandling av konstipasjon
ECSP951559A (es) Inhibidores de la 5- lipoxigenasa
FI972676A (fi) 4,4-(disubstituoitu)sykloheksan-olimonomeerejä ja vastaavia yhdisteitä

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee